Schalop Lee Troy bought LTRN
January 9, 2026 · Form 4 insider transaction
Schalop Lee Troy bought 18,460 shares of Lantern Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,460
Price
$0.00
Total value
N/A
InsiderSchalop Lee Troy
Role—
CompanyLantern Pharma Inc. (LTRN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after18,460
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 12-month period commencing February 9, 2026.